Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-016714
Filing Date
2024-04-26
Accepted
2024-04-26 17:03:01
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 313123
2 ex31-1.htm EX-31.1 6448
3 ex31-2.htm EX-31.2 6372
  Complete submission text file 0001493152-24-016714.txt   578414

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adxs-20231231.xsd EX-101.SCH 3024
5 XBRL LABEL FILE adxs-20231231_lab.xml EX-101.LAB 36884
6 XBRL PRESENTATION FILE adxs-20231231_pre.xml EX-101.PRE 24152
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7199
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36138 | Film No.: 24885008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)